🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hybrid Resin Composite vs. Hybrid Ceramic Onlays for Restoring Carious Molars

RecruitingNAAges 18 Years - 50 YearsAllPeter Medhat Youssef Gerges
NCT06820840 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to compare the clinical performance of hybrid resin composite and hybrid ceramic onlays in restoring carious molars. It will also evaluate the wear resistance of both materials. The main questions it aims to answer are: * Does the hybrid resin composite or hybrid ceramic onlay perform better in clinical settings over time? * How much wear occurs in each type of onlay over 18 months? Researchers will compare SHOFU Ceramage (hybrid resin composite) to SHOFU Block HC Hard(hybrid ceramic) to see which material performs better in restoring molars with extensive caries. Participants will: * Receive either a hybrid resin composite or hybrid ceramic onlay for their molar cavities. * Visit the clinic for checkups at baseline, 6 months, 12 months, and 18 months. * Undergo visual assessments of their restorations and quantitative wear analysis during follow-up

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Able to tolerate necessary restorative procedures * Willing to sign the informed consent * Accepts the follow-up period Exclusion Criteria: * ICDAS 4/5 cavities in first and second permanent molars * Onlay cavities with at least one cusp coverage * Patients with acceptable oral hygiene
💊

What it tests

  • SHOFU Block HC Hard
  • SHOFU Ceramage
📍

Where

1 site
Cairo University
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy